Medical leaders demand reform of abortion laws in England and Wales, citing rising prosecutions of women and girls, and calling for legislation that treats abortion as a healthcare issue, not a criminal one.

Glasgow’s new consumption room marks a significant step in drug policy, focusing on harm reduction and providing respectful care while addressing the ongoing crisis of drug deaths and addiction in Scotland.

Caroline Cerny’s article in the BMJ highlights the rise of smoking in popular entertainment, stressing the responsibility of media creators and platforms to avoid glamorizing addiction, especially for young audiences.

Varenicline, marketed to help quit vaping, comes with severe side effects that may be worse than the effects of quitting itself. Consider non-pharma solutions like Allen Carr's EasyWay for a safer, effective approach.

Vapes, initially designed to help smokers quit, quickly evolved into a youth-targeted addiction product. Learn how this market exploded and the role Allen Carr’s EasyWay plays in tackling addiction across various substances.

Robert Sapolsky’s book "Determined" explores how human decisions are shaped by external factors, challenging the concept of free will. This is central to understanding the addiction economy and tech's influence on our choices.

Nestlé's launch of protein-rich, ultra-processed foods for Ozempic users raises questions about the food industry's role in providing real nutrition and how we can reimagine the future of healthy food solutions.

With bowel cancer rates rising rapidly in young adults, it’s time to address the impact of ultra-processed foods and create a healthier food environment through regulation and better access to nutritious options.

New weight-loss drugs like Ozempic may help patients shed pounds, but are we ignoring the importance of a balanced lifestyle and long-term health beyond just weight loss?

Drawing from the failures of past industries, here are 7 essential lessons for regulating AI—ensuring innovation benefits society while avoiding the catastrophic consequences of unchecked markets.

Is addiction a result of personal biology or a manipulated environment? This thought-provoking piece explores how the Addiction Economy manipulates individuals through addictive products and environments, challenging both the Biological and Moral models.

Fast food chains near schools are skyrocketing, raising questions about local councils’ role in regulating these outlets and the addictive nature of these products on high streets.

New "Smart Vapes" target kids with inbuilt games, social media links, and location tracking—highlighting the growing need for anticipatory regulation and stronger laws to protect youth.

Oxford’s “Word of the Year” highlights society’s decline in intellectual engagement—how overconsumption of trivial content shapes our minds and culture.

Fentanyl-related deaths decrease as cartels alter production methods—how changes in addiction product design could influence overdose rates and the future of drug policy.

Dr Dolly van Tulleken and Henry Dimbleby's new Nesta report highlights the major obstacles to addressing food-related ill-health, which align with the 5 Drivers of the Addiction Economy identified by Joe Woof and me. Key issues include disinformation and political inaction.

Cigarette companies like Philip Morris and BAT are producing fruity flavored cigarettes targeting children in South America while claiming to help smokers quit with vapes in the UK. Corruption and lobbying prevent necessary regulations to stop this harm.

Gambling has become one of the most predatory sectors in the Addiction Economy, with the state’s failure to regulate fueling industry harm. The move to keep voluntary donation systems in place highlights the industry's influence over harm reduction efforts

Chris Van Tulleken’s documentary and article highlight addiction to UPF, cigarettes, and social media. However, the real issue lies in the addictive products and environments, not an “addictive brain,” with over a billion people affected globally

Ahead of the Tobacco and Vapes Bill's second reading, the push to phase out vapes alongside cigarettes continues. Advocating for vapes as a quitting tool, not a new addiction, the proposal includes research on non-pharma cessation and tighter regulation